Downstream processing aspects of a stable form of amorphous itraconazole exhibiting enhanced dissolution properties were studied. Preparation of this ternary amorphous solid dispersion by either spray drying or hot melt extrusion led to significantly different powder processing properties. Particle size and morphology was analysed using scanning electron microscopy. Flow, compression, blending and dissolution were studied using rheometry, compaction simulation and a dissolution kit. The spray dried material exhibited poorer flow and reduced sensitivity to aeration relative to the milled extrudate. Good agreement was observed between differing forms of flow measurement, such as Flow Function, Relative flow function, Flow rate index, Aeration rate, the Hausner ratio and the Carr index. The stability index indicated that both powders were stable with respect to agglomeration, de-agglomeration and attrition. Tablet ability and compressibility studies showed that spray dried material could be compressed into stronger compacts than extruded material. Blending of the powders with low moisture, freely-flowing excipients was shown to influence both flow and compression. Porosity studies revealed that blending could influence the mechanism of densification in extrudate and blended extrudate formulations. Following blending, the powders were compressed into four 500 mg tablets, each containing a 100 mg dose of amorphous itraconazole. Dissolution studies revealed that the spray dried material released drug faster and more completely and that blending excipients could further influence the dissolution rate.
Introduction
Amorphous solid dispersions (ASD) have received a surge in research interest over recent decades, due to the large and increasing number of poorly soluble drugs on today's market (Brouwers et al., 2009; Leuner and Dressman, 2000) . Although several examples of commercial ASDs exist (Huang and Williams III, 2017) , the technology has sometimes lost out to other bioavailability enhancement strategies, often due to problems with recrystallisation or perceived difficulties in downstream processing. Although publications addressing recrystallisation issues are manifold, far less research has been reported addressing the issues of flow and compression (Demuth et al., 2015) .
Efficiency of flow and compression can affect processing times and tablet quality. Bridging, arching or rat-holing for instance, can lead to increased processing times, inaccurate die fill and unacceptable dose variation. Compression issues can cause sticking, picking or flaking of tablets and ultimately reduction in patient compliance (Jain, 1999; Leuenberger and Rohera, 1986; Patel et al., 2006) . In an age of greater focus on quality by design (QbD), global manufacturing competition and 'right first time' demands, the need to resolve or minimise such issues at the research stage is stronger than ever.
The purpose of this study was to assess the impacts of spray drying (SD) and hot melt extrusion (HME) on the flow, compression and dissolution characteristics of an ASD containing itraconazole (ITZ) . Comparisons between properties of amorphous dispersions prepared by SD and HME are popular, (Davis and Walker, 2018) although most of these do not specifically deal with downstream processing issues. We have recently reported the preparation of a novel ternary ASD using both SD and HME . Ternary dispersions have become increasingly popular (Davis and Walker, 2018) in the struggle to meet the sometimes competing demands of ASDs: increased bioavailability, adequate stability, efficient processing, the use of existing plant equipment and bearable costs. The formulations, containing drug and excipient polymers Soluplus® and HPMCP, displayed excellent stability and enhanced dissolution in both studies Davis et al., 2017) . The following is an account of the impact of preparation on the downstream processing of one of those formulations.
Materials and methods

Materials
ITZ (> 99%) was purchased from Xi'an Lyphar Biotech Ltd. Accurate analytical standard of itraconazole (99.8%) for HPLC calibration was purchased from Sigma Aldrich. Polymers Soluplus® & HPMCP HP-55 (HPMCP) were donated by BASF and Shin Etsu respectively. Excipients Avicel 101 & Avicel PH 200 LM were donated by FMC and Mannogem granular was donated by SPI Pharma. Solvents and chemicals were purchased from Sigma-Aldrich and were of HPLC and reagent grade.
Spray drying
Spray drying was conducted using a Büchi B-290 mini spray dryer connected to a B-295 inert loop. A 2-fluid pneumatic nozzle (0.7 mm) was fitted and liquid feedstock was pumped at 4 mL/min (15%). Drying nitrogen was set at maximum by fixing the aspirator at 100% (35 m 3 / h). A solution of ITZ-Soluplus®-HPMCP (30-40-30 w/w) in dichloromethane-methanol 7-10 (v/v) (1.0 L, 10.0% w/v) was pumped through the nozzle at inlet temperature 100°C, producing an outlet temperature of 65 ± 2°C. High yields (88.6%) were achieved by using high spray gas rates (670 L/h) and attaching the high efficiency cyclone option. Powdered product was immediately transferred into a stainless steel pan and dried overnight in a vacuum oven at 40°C and 10 −2 mBar to ensure complete removal of residual levels of solvent. Powder was then stored in a sealed glass bottle in a desiccator over anhydrous molecular sieves.
Hot melt extrusion and milling
Itraconazole, Soluplus® and HPMCP 30:40:30 (w/w) (50 g) were pre-mixed by hand in a polythene bag, having first removed larger particles of HPMCP, by passing through a 435 µm sieve. The pre-mixed powders were then manually fed into a Three-Tec twin-screw extruder (Three-Tec GmbH, Germany) with a barrel diameter of 12 mm and an L/D ratio of 40:1. The set points of the six heating zones, from feed to die, were 80, 110, 120, 140, 150 and 150°C, respectively and screw speed was maintained at 15 rpm throughout. Following extrusion the material was milled for 1 min at 20 Hz using a 25 mL stainless steel jar attached to a Retsch Mixer Mill MM 400 ball mill (Retsch GmbH, Germany). Milled extrudate was sieved through 435 and 90 µm sieves and the 90-435 µm and < 90 µm fractions were stored separately in sealed glass bottles in a desiccator over anhydrous molecular sieves.
Scanning electron microscopy (SEM)
Drug polymer formulations were attached to double sided carbon tape and sputter coated with a thin layer of gold followed by imaging using a Joel CarryScope JCM-5700 scanning electron microscope. Micrographs were recorded at various magnifications, using a beam acceleration voltage of 5 kV, a spot size of 40 and a working distance of 12.
Powder rheometry
Powder flow was analysed using an Freeman FT4 powder rheometer in a manner previously reported (Freeman, 2007) . Stability and Variable flow rate was performed in the 25 mm vessel, Aeration in the 25 mm vessel and Shear in the 10 mL and 1 mL vessels.
Compaction simulation
Powders were tableted using a Gamlen R-series tablet press containing a 500 kg load cell and 6 mm punch and die. The material was subjected to uniaxial compression tests to form flat-face cylindrical tablets with a target weight of 90 mg. Punch load and displacement were measured during compression and the effect of compaction forces from 0.5 to 5 kN, equivalent to pressures of 17-173 MPa, was studied. Tablet hardness, defined as the diametral force required to break the compact, was investigated using a PharmaTest hardness tester (Pharma Test Apparatebau AG, Germany) immediately after tabletting.
True density
The true density of the extruded and spray dried products and powder blends was measured under ambient conditions using an helium pycnometer (AccuPyc II 1340, Micromeritics Inc., Norcross, GA). The volume of the pycnometer was verified with a standard before carrying out analysis. During sample analysis five purge cycles were recorded for samples and the reported result is an average of measurements made on three different days.
Formulation and tabletting
ASD products and excipients were accurately weighed as described in Table 4 and the individual components were vortex mixed for 2 min in 10 mL vessels. The resultant prototype tablet formulations were pressed according to scalable parameters determined through small scale compaction simulation performed on 90 mg material. Blends were weighed into a 0.5 in. (12.7 mm) diameter die and then pressed at 1000 kg pressure on a manual hydraulic tablet press to form flat-face cylindrical tablets with a target weight of 500 mg.
In-vitro dissolution studies
Drug release studies were carried out using non-sink conditions, in a USP type II apparatus, PharmaTest dissolution tester (Pharma Test Apparatebau AG, Germany), with 900 mL 0.1 N HCl buffer (pH 1.2) per well, a paddle speed of 100 rpm and a temperature of 37 ± 0.2°C. Formulated tablets of mass 500 mg, equivalent to 100 mg of drug were added to the dissolution vessel (n = 3), with start times staggered by 2 min. 5 mL aliquots of media were withdrawn at predetermined intervals (0.25, 0.5, 0.75, 1, 2, 3, 4, and 6 h), filtered through a 0.45 μm polytetrafluoroethylene (PTFE) syringe filter and then the first 1 mL of filtrate was discarded. 500 µL of the filtrate was subsequently added to 500 µL of HPLC mobile phase in 2 mL HPLC vials. 5 mL of fresh medium was immediately replaced following each withdrawal.
High performance liquid chromatography (HPLC)
Dissolution samples were analysed using an Agilent (Agilent, Little Island, Cork) 1260 Infinity II high performance liquid chromatography system, comprising of quaternary pump G1311B and diode array detector G1315D set at wavelength 263 nm. The thermostated column compartment G1316A was set at 25.0°C and equipped with a Kromasil 100 C18 5 µm 250 × 4.6 mm (Kromasil, Mainz, Germany) RP-HPLC column. The system was operated under isocratic flow at 1 mL/min using, a mobile phase of acetonitrile:water:diethanolamine (69.95/30/ 0.05, v/v/v) . Samples were injected from autosampler G1329B in volumes of 20 µL and data was collected and analysed by Agilent OpenLAB CDS Chemstation software. Standards of ITZ (99.8% purity) were prepared from a stock solution of 1 mg/mL in methanol, to quantify the levels of drug in the dissolution media.
Results and discussion
Preparation of amorphous solid dispersions by spray drying and hot melt extrusion
In our previous studies we discovered that it was possible to prepare M.T. Davis et al. International Journal of Pharmaceutics 544 (2018) 242-253 novel ternary amorphous dispersions of BCS class II drug itraconazole by hot melt extrusion and by spray drying . Following rational polymer selection (Davis et al., 2015) , these blends proved to have excellent stability and enhanced dissolution profiles. As design of experiments (DoE) had previously been performed during formulation design, only one blend was selected for downstream processing. A ternary ratio of itraconazole-Soluplus®-HPMCP 30-40-30 (w/w) was selected to test a high drug load and simultaneously facilitate HME processing, by choosing a Soluplus® ratio that was slightly higher than that of HPMCP. Particle size is a critical factor in powder flow. Often the particles from spray drying processes are very small (< 10 µm) (Vehring, 2008) , which can be excellent for dissolution, but challenging for powder flow. It is possible to increase particle size by changing nozzle type to a pressure nozzle (Beyerinck et al., 2010) , processing parameters, drier geometry or feed stock concentration. Of these options, the most directly available was an increase in feedstock concentration, although it is likely that a pressure nozzle would be more effective. More concentrated feed solutions produce more viscous droplets and hence larger particles (Vehring, 2008) . For this reason the feed was prepared at 10% (w/v), following optimisation experiments on the dichloromethane-methanol solvent system , leading to an optimal ratio of 7-10 (v/v). In addition, the yield of the spray dried powder was optimised by tuning processing parameters. In particular, when the spray gas rate was increased from 25 mm (301 L.h ) on the flow meter, the yield increased from 51% to 89%.
With hot melt extrusion, it was less difficult to prepare the quantities of material required (at least 100 g), as the materials are not diluted in liquid before feeding to the equipment. However, it was found that sieving, pre-mixing and manually feeding the ternary materials was favourable, to promote adequate mixing and prevent system overload by excess torque. Early runs lead to the production of opaque amber material and excessive torque. The torque issue was ameliorated by modifying the ternary blend mixture from itraconazole-Soluplus®-HPMCP 30-35-35 to 30-40-30 (w/w), as the HPMCP was difficult to extrude, but the Soluplus® processed very well. In addition, the adjustment of zone temperatures by increasing zones 4 and 5 from 130°C and 140°C to 140°C and 150°C respectively, resulted in production of glassy yellow material. After cooling, the glassy extrudate was milled, sieved and stored.
Cleaning of the extruder was also challenging, requiring addition of pure Soluplus® as a 'cleaning polymer', followed by hot removal of thermocouples, hot removal of barrels from screws, cooling, separation of barrel blocks using levers and finally immersion in warm 1% surfactant with sonication.
Particle size and morphology
The impact of particle size and morphology on powder flow is well known and can drastically effect the efficiency of pharmaceutical powder processes, such as die filling (Gallo et al., 2011; Hancock et al., 2002; Nokhodchi et al., 2007; Sinka et al., 2004; Sivasankaran et al., 2010; Wu and Cocks, 2004; Xie and Puri, 2006) . Variation in powder composition or flow can lead to unacceptable deviations in tablet weight and content uniformity, possibly leading to the rejection of a batch in extreme circumstances. Poor flow can potentially also lead to inefficient or even dangerous processes on the plant, caused by bridging or caking of powder masses during storage in containers or silos and the potential for powder flooding. Because spray dried powder contains particles mostly < 10 µm and milled extrudate < 90 µm (or 90-435 µm, for the larger sieved extrudate fraction), the cohesion and flow of these powders will differ profoundly and require differing hopper angles, orifices or alternative storage design for safe and efficient handling.
Scanning electron microscopy (SEM) was performed on the materials to provide insight into particle size and morphology. Itraconazole was received as relatively flat, wedge-like crystals (Fig. 1a) approximating 40 µm length by 10 µm width, with a mostly smooth surface that nevertheless displayed several brittle shards. Soluplus® was received as much larger, approximately spherical granules ( Fig. 1b) with a diameter approximating 250 µm. HPMCP (Fig. 1c ) was received as pod-or cocoon-like elongated particles approximating 350 µm by 70 µm, with a smooth but broken surface. The physical mix was a combination of the above, although the difference in size and shape between the small itraconazole particles and the large HPMCP particles was particularly apparent (Fig. 1d) . This shaped the decision to sieve the HPMCP before powder blending and extrusion.
The extruded particles were ball milled and sieved prior to SEM analysis. The particles appeared as irregularly shaped granules, comprising considerably more material per granule than the spray dried particles. There were many rough spots on the surface of each individual granule, representing possible areas for particle interlocking and cohesion. Particles were typically 50 µm × 55 µm in the < 90 µm sieved fraction ( Fig. 1e ) and 240 µm × 350 µm in the 90-435 µm sieved fraction (Fig. 1f) . The spray dried sample appeared as a combination of some hollow spheres with diameters of up to 30 µm ( Fig. 1g) , some burst hollow spheres (Fig. 1h ) of similar diameter, but mostly crumpled spheres of less than 10 µm, that had grouped into agglomerates of various shapes, with 40-60 µm in total diameter. The particles size of the spray dried material in this study represented an increase to that of our previous work, where a lower feed concentration of 0.5% (w/v) typically led to particle diameters of 1.5-2.4 µm, depending on formulation . Although increasing the feed 
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Powder flow
Powder stability during flow
Because unknown powders may be prone to attrition, agglomeration or caking, it is important to begin by measuring whether the powder will change during the course of testing. To discover if the flow properties alter under the stresses imposed during flow, (Iveson et al., 2001; Salman et al., 2002) the 'stability program' runs the powder through a series of identical conditioning and test cycles: if the powder is stable then the results from each measurement are similar. This is observed as a straight line from points 1 through to 7 in Fig. 2 . The stability index, defined in Eq. (1), is the ratio of energy in test 1 to energy in test 7:
Generally, a stable powder will have an SI approximating 1, powders with SI > 1 are unstable, affected by de-aeration, agglomeration, segregation, moisture uptake or electrostatic charge and powders with SI < 1 are unstable, affected by attrition, de-agglomeration, overblending or coating of the vessel and blade by an additive (Freeman, 2007) . The data in Figs. 2 and 3 demonstrated that milled extrudate (HME & BM), physical mixture, itraconazole and spray dried ASD were largely stable to flow rate changes, with SI values of 0.96 ± 0.06, 1.08 ± 0.11, 0.97 ± 0.18 and 1.24 ± 0.26, respectively. Only excipients Soluplus® (1.91 ± 0.35) and HPMCP (1.35 ± 0.17) were unstable with respect to flow stress, with the stability results for HPMCP particularly inconsistent (data not shown). The underlying cause for the instability may be connected to static charge accumulation in HPMCP during testing.
Powder variable flow rate during flow
The rate at which powders are handled and transferred varies and the sensitivity of a powder to this is an important factor. Often, cohesive powders are more sensitive to changes in flow rate than non-cohesive or granular materials. During the variable flow rate test (Fig. 2) , the flow rate is reduced from 100 mm/s to 10 mm/s over tests 8-11. The flow rate index (FRI) is given by Eq. (2):
Usually, a high flow rate sensitivity (usually for very cohesive powders) is depicted as FRI > 3.0; an average flow rate sensitivity (including most powders) lies between 3.0 > FRI > 1.5; flow rate insensitive materials (with large PSD or surface coating) have FRI ≈ 1.0 and pseudoplastic or Neutonian Flow rates (such as powders containing flow enhancers like magnesium stearate) are found with FRI < 1.0 (Freeman, 2007) .
As depicted in Figs. 2 and 3 the experimental FRI values recorded were as follows: itraconazole 1.89 ± 0.03, Soluplus® 1.28 ± 0.06, HPMCP 1.63 ± 0.24, HME/BM 1.40 ± 0.02; physical mix 1.68 ± 0.11 & spray dried 3.73 ± 0.35. So, most of the materials can be classified as having average flow rate sensitivity, with the Soluplus® and milled extrudate edging towards being insensitive. The clear exception was the spray dried material, with a high FRI value of 3.73, as would be expected for a cohesive powder comprised of very small particles. The difference between the spray dried ASD and the milled extrudate ASD was 3.73-1.40 = 2.33 units. It would therefore be reasonable to expect a significantly different sensitivity of these two ASDs to flow rate during processing, despite their identical chemical compositions.
Powder aeration studies
The bulk properties of all powders are to some extent influenced by air because the inter-particulate spaces themselves contain air. The volume of air impacts interparticular interactions and flow. Some powders are readily aerated and require only modest quantities of air to transform into a fluidised bed. Others are cohesive and therefore not easily aerated, although the flow properties may still improve with increasing air entrainment. The aeration ratio (AR) is given by the equation:
Powders with AR ≈ 1 are not sensitive to aeration and are generally very cohesive. An average sensitivity to aeration with 2 < AR < 20 is found for most powders. Very sensitive powders with AR ≫ 20 will most likely become fluidised easily. Referring to Fig. 4 , the three raw materials and the two ASD powders were measured on the aeration program and produced the following AR results: HPMCP = 1.38-1.68 (not sensitive, very cohesive); Soluplus® = 0.45-0.54 (not sensitive, special case); itraconazole = 1.62-3.51 (cohesive to average); milled extrudate = 45.9-58.2 (very sensitive, non-cohesive); spray dried = 1.73-2.02 (not sensitive, very cohesive) (Freeman, 2007) .
These results can be rationalised by considering the particle size and morphology of the powders (Fig. 1 & Section 3 .2). HPMCP particles are elongated along one axis and typically several hundred µm long, so a preference for horizontal stacking may add to cohesion. Soluplus is Fig. 2 . Stability and variable flow rate data recorded on an FT4 powder rheometer for ASD powders of itraconazole-Soluplus®-HPMCP 30-40-30 (w/w/ w), physical mix and pure drug. Tests 1-7 are performed at constant blade tip speed and measure stability, a stable powder will show an approximately flat straight line. Tests 8-11 feature a reduction in blade tip speed and measure the sensitivity of powder to flow rate, typically more energy is consumed as the blade passes at a slower speed. Measurements were recorded in triplicate.
spherical and around 300 µm in diameter, the spherical shape is quite aerodynamic and allows a laminar flow around the spheres, leading to the very low AR value of 0.48. This may also explain the unexpected requirement for more energy as the blade flows through the sample at higher aeration velocities. Itraconazole comprises straight, flat crystalline wedges of approximately 10 µm × 40 µm, so it is unsurprising that this material is also cohesive and AR insensitive. The test on the milled extrudate was performed prior to sieving. The particles contain a significant fraction of larger particles (> 300 µm), with various shapes and sizes, so the material was non-cohesive and very sensitive to aeration. Finally, the spray dried material contains hollow, burst and crumpled spheres, with many particles < 10 µm. The material is very cohesive due to the tiny particle size and therefore AR insensitive
The average AR values for the milled extruded and spray dried samples were 50.23 ± 6.89 and 1.88 ± 0.15 respectively, a difference of 48.35 AR units, representing a significant difference in sensitivity towards aeration. The result has implications for understanding Würster coating and other processes that intentionally use air or for flow by gravity (Bruni et al., 2007; Freeman, 2007; Leturia et al., 2014) .
In particular, die filling during tabletting requires both that the powder fill the die by gravity and also that the air in the die exits easily through the particles as they ingress (Sinka et al., 2004; Wu and Cocks, 2004) . As speed of tabletting increases this becomes more important.
Powder shear testing
Shear cell testing is perhaps the most studied and understood flow test performed using powder rheometry (Fitzpatrick et al., 2004; Jenike, 1964; Schulze et al., 2008; Schwedes, 2003; Walker, 1966) . The procedures and testing sequences have been reported elsewhere (Freeman, 2007) , but briefly consist of powder conditioning, consolidation, vessel splitting, re-consolidation and finally shear testing.
The tests were performed in triplicate to increase accuracy. FT4 software enabled automatic construction of Mohr circles, providing valuable data such as cohesion (C), unconfined yield strength (UYS), major principle stress (MPS), minor consolidation stress (MCS), angle of internal friction (AIF), Peschl's Relative Flow Function (Rel P ) (Peschl and Colijn, 1977 ) and Jenike's Flow function (FF of ffc) (Ennis et al., 2007; Freeman, 2007; Jenike, 1964) . The equations for FF and Rel P are given Fig. 3 . The stability index (SI) and flow rate index (FRI) values recorded in triplicate for itraconazole, Soluplus®, HPMCP, physical mix, HME/BM powder and spray dried powder by the FT4 powder rheometer. An SI value of 1.0 ± 0.1 indicates the powder is not sensitive to flow stress, for example the HME/BM result. An FRI > 3.0 indicates that the powder is highly sensitive to flow rate and most likely cohesive, such as the value of the spray dried sample. Fig. 4 . Aeration studies on raw materials itraconazole, Soluplus®, HPMCP and ASD powders prepared by hot melt extrusion then ball milling (HME & BM) or by spray drying. Data was recorded in triplicate on an FT4 powder rheometer. During the test, a blade is passed at 100 mm/s tip speed through a bed of powder while air is introduced at the base at progressive velocities. The extent by which the flow energy is reduced is a function of the physical properties of the powder (such as cohesion) and provides the aeration ratio (AR).
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In Fig. 5 , the yield loci (plot of applied normal stress vs shear stress) of itraconazole, the physical mixture and the two ASD powders were plotted with the corresponding shear parameters reported in Table 1 . The most frequently reported value derived from shear cell data to describe flowability is the Jenike Flow Function (FF of ffc) (Freeman, 2007; Jenike, 1964) . The FF values for itraconazole (2.03 ± 0.03) and the spray dried ASD (3.45 ± 0.18) indicated that they were cohesive, the physical mixture was very cohesive (1.98 ± 0.25) and the milled extruded ASD was free-flowing (57.01 ± 53.62). The low standard deviation values indicated that repeatability was excellent for the cohesive powders but rather poor for the free-flowing extrudate, demonstrating that this test was more accurate for cohesive powders (Freeman, 2007) . Similarly (but with subtle differences in cohesive ranking), the Relative Flowability (Rel P ) (Peschl and Colijn, 1977) values indicated that itraconazole and the physical mix were extremely cohesive, the spray dried ASD was very cohesive and the milled extrudate was cohesionless (Tables 1 & 3) .
The highest values of Unconfined Yield Strength (UYS) were found in the physical mixture (11.83 kPa) and itraconazole (10.75 kPa), with much lower values for the spray dried (4.14 kPa) and milled extrudate (2.98 kPa) ASDs, respectively. This was expected, as more cohesive powders will generally have higher values for UYS (Freeman, 2007) . In addition, a steeper yield locus often represents a powder that is more sensitive to increasing levels of consolidation. The highest AIF value was for the physical mixture (44.09 ± 8.75°), followed by itraconazole, roughly equal to the extruded/milled ASD and finally the lowest value was for the spray dried ASD (27.75 ± 0.61°). Therefore the pure drug was most sensitive to increasing consolidation and the spray dried ASD was least sensitive overall and less sensitive than the milled extrudate (by 8.64°on average). Consolidation results have implications for packaging, shipping and processing considerations.
A comparison of powder flow testing parameters
To better understand the accuracy and precision of the various parameters used to measure flow, simple mass/volume measurements were taken to calculate the Hausner ratios and Carr's indices for the powders. Although these parameters have little theoretical basis, they are easily obtained and have been used to describe powder flow for many decades, so their inclusion seems worthwhile. The FT4 rheometer conditions the powder prior to recording bulk density and this imparted a high degree of repeatability (accuracy) on the values obtained (Table 2) , with standard deviations (n = 3) between 0.01 and 0.08 g/ mL for the 5 powders included. Conversely, the 'measured' values were simply taken as a recording of pouring the powders from their containers in whatever state they happened to be resting in (raw materials were stored in 1 kg bags (HPMCP), 5 kg bottles (Soluplus) and 1 kg bottles (itraconazole) and ASDs (100 g) in sealed glass jars in a desiccator) into a pre-weighed graduated cylinder then re-weighing to get the density and this was performed once. Although the repeatability of bulk density values for Soluplus® and HPMCP from the FT4 and direct measurements was excellent ( ± 0.01 g/mL) and those of spray dried and milled extrudate were comparable ( ± 0.05 & 0.10 g/mL respectively), the value for itraconazole differed wildly ( ± 0.19 g/mL, or 37%) ( Table 2 ). The net effect of these differences is demonstrated by Carr index values of 43.39 and 10.71 for itraconazole depending on the bulk density value taken -this clearly demonstrated the requirement for a more consistent method for measuring powder flow, particularly for powders like itraconazole that are both cohesive (C = 2.55 ± 0.17 kPa) and sensitive to consolidation (UYS = 10.75 ± 0.56).
To explore these points further, the various flow parameters obtained from the FT4 rheometer were tabulated with the Hausner ratio Fig. 5 . Yield locus plots for itraconazole, physical mixture and ASD powders prepared by spray drying and by hot melt extrusion (followed by ball milling), recorded in triplicate on an FT4 powder rheometer. Corresponding shear parameters are recorded in Table 1 . Davis et al. International Journal of Pharmaceutics 544 (2018) 242-253 and Carr's index in Table 3 . For itraconazole, interpretations of values for the Flow Function, Relative Flowability, Flow rate index, Aeration ratio, Hausner ratio and Carr's index were in good agreement with each other: cohesive, extremely cohesive, average flow rate sensitivity, average aeration sensitivity, extremely poor flow and extremely poor flow, respectively. Similar agreement was observed for Soluplus®, HPMCP, physical mixture, spray dried ASD and the milled extrudate. The high level of agreement between results suggests precision in the flow parameters from the instrument. In general, the accuracy of the measurements from the FT4 was excellent. However, while analysing the milled extrudate sample, although the FRI measurement was very accurate (SD ± 0.02), the results for Rel P and FF were very inaccurate ( ± 40.07 and ± 53.62 respectively), reflecting the lack of sensitivity of shear testing towards larger particles.
3.3.6. The effect of additional excipients on ASD powder flow To see if flow could be improved by blending with appropriate excipients, the spray dried and the milled extrudate ASDs were blended (separately) with Avicel PH 200 LM (Av200) and Mannogem granular (ManG) to give four formulations (Table 4) . In order to enhance powder flow, these excipients had relatively larger particle sizes (on average 200 µm and 400 µm, respectively), although the difficulty in homogenously mixing powders of differing sizes is well documented. Furthermore, both excipients were specially treated commercial forms of MCC and mannitol respectively, both known for their excellent compression characteristics. Thirdly, due to the moisture-sensitive nature of amorphous dispersions, both excipients were selected for their low moisture ('LM') or non-hygroscopic (mannitol) properties. To achieve a 100 mg drug dose in the final tablet (the standard itraconazole dosage) required 333.3 mg (66.6% w/w) of the ASD, allowing only 150 mg (30% w/w) of excipient for the 500 mg total, with disintegrant and lubricant accounting for the remaining 3.4% (w/w).
In order to analyse the effect of these excipients on powder flow, further shear studies were performed using the 1 mL annular shear cell (due to lower powder quantities). The yield locus plots are depicted in Fig. 7 with shear data in Table 5 . Considering the spray dried ASD and formulations, addition of Av200 reduced cohesion by 0.46 kPa and increased FF by 1.01 units. Conversely, addition of ManG increased cohesion by 0.25 kPa and decreased FF by 0.25 units. Considering milled extrudate the picture was dissimilar: addition of Av200 reduced cohesion by 0.24 kPa and increased FF by 3.56 units, but addition of ManG further reduced cohesion by 0.46 kPa and further increased FF by 14.18 Table 3 Comparison of material parameters related to flow. Flow function, Relative flowability, Flow rate index and Aeration ratio were performed in triplicate on the FT4 powder rheometer. Hausner ratio and Carr index were measured using an accurate balance and graduated cylinder and are provided for comparison purposes.
Interpretations are provided in parentheses, see Section 3.3.5 for discussion. Table 4 Prototype tablet formulations containing ternary spray dried and milled/extruded (HME/BM, sieve fraction < 90 µm) itraconazole ASD. Each tablet was 500 mg in size with a drug dose of 100 mg. The filler excipients Avicel PH 200 LM (MCC) and Mannogem granular (mannitol) were selected for their favourable compression, flow and low moisture properties. Disintegrant Ac-di-sol (croscarmellose sodium) was used at 2.3% (w/w) and lubricant magnesium stearate was used at 1% (w/w). Davis et al. International Journal of Pharmaceutics 544 (2018) 242-253 units. Clearly the enhancement or hindrance of flow by addition of further excipients is a combination of many complex factors, is specific to the precise set of interparticulate forces acting between the given excipient and dispersion and is therefore difficult to predict or simulate.
Compression
Tabletability and compactability of raw materials and ASDs
In order to better understand the effects of ASD preparation on tabletability (compaction pressure vs tensile strength) and compactability (solid fraction vs tensile strength), the materials were examined using a Gamlen tablet press (GTP) and a PharmaTest hardness tester. The data was converted into plots according to Eq. (6):
where, σ is tensile strength, F is the load required to fracture the tablet, D is the tablet diameter and H the tablet height (Banker et al., 2002; Endicott et al., 1961; Fell and Newton, 1970) . The spray dried material produced a stronger compact than milled extrudate at similar compaction pressures (Fig. 6a) . This was attributed to the bonding area, i.e. the effective surface area taking part in physical interparticulate bonding, which is greater for smaller particles (Olsson and Nyström, 2001) . Tablet tensile strength is related to both bonding area and bonding strength with the overall strength due to an interplay between the two (Osei-Yeboah et al., 2016; Sun, 2011) . Assuming that a minimal amount of brittle fracture occurs in the powders during the initial stages of compression, the greater mechanical strength of spray dried compacts can be partly attributed to the smaller particle size produced by spray drying relative to milled extrudate.
The strongest compact was formed with pure HPMCP (slightly stronger than pure Avicel 101) and the weakest with Soluplus® (Fig. 6a) . It is also possible that differences in excipient hygroscopicity impacted compact strength, by introducing moisture mostly during ambient storage or during weighing and compression, causing more hygroscopic materials (such as HPMCP) to form stronger compacts (Malaj et al., 2010; Sun, 2011) . Confirmation of this would require further testing.
The compactability (tensile strength vs solid fraction) profiles (Fig. 6b) showed a range in tablet tensile stress with solid fraction. Soluplus® was very compacted at the tensile strengths studied, with values over 0.95. Milled extrudate fractions were comparable to values obtainable for a typical filler like Avicel 101 (MCC), but spray dried ASD had lower solid fraction ranges, up to 0.80. HPMCP had the lowest values, up to 0.68, showing the possibility for further compaction at higher pressures.
Tabletability and compactability of prototype tablet formulations
Formulation of spray dried powders with Av200 (Formulation 1) improved tabletability, however inclusion of ManG (Formulation 2) produced softer tablets (Fig. 8a) . Neither Av200 nor ManG improved the tabletability of extruded powders, with both Formulation 3 and Formulation 4 producing softer tablets than the milled extrudate alone. Addition of either excipient to the milled extrudate ASD produced a more linear relationship between compaction pressure and tensile Table 4 , for shear data see Table 5 and for discussion see Section 3.3.6. strength above pressures of 115 MPa, and this was more marked with the ManG formulation.
Compactability values were higher for all extruded material formulations, although inclusion of both Av200 and ManG resulted in enhanced compactability values for all of the spray dried and extrudate formulations (Fig. 8b) .
Compressibility of prototype tablet formulations
Tensile strength measurement is carried out on the tablet following compression and is an out-of-die method, however analysis of the powder in-die during compression provides further information, especially on elastic deformation. The non-linear behaviour observed between tensile strength and compression pressure of the extruded powder, Formulation-3 and Formulation-4 provided the opportunity to investigate whether a change in the mechanism of densification from plastic to elastic deformation had occurred. Fig. 9 compares the behaviour of extruded powder and extrudate formulations 3 & 4 in-die, illustrating both the change in porosity with compression pressure (dotted line) and the resulting Heckel plot, based on the logarithmic change in porosity (full line). Porosity was calculated by determining the solid fraction using the density of a compact from its mass and volume then dividing by the true density (Eqs. (7) and (8) 
= − Porosity Solid fraction 1
For each of the three Heckel plots, an initial non-linear region was observed, typically attributed to particle rearrangement (Heckel, 1961; Shapiro, 1995) or particle fragmentation (Duberg and Nyström, 1982) . This was followed by a linear region indicating plastic deformation (Heckel, 1961) , then a further non-linear region signifying elastic deformation of the powder bed (Sun and Grant, 2001) . While all three regions are present in each of the plots, the nature of the regions varied from powder to powder. The extruded material (Fig. 9a) exhibited a shortened plastic deformation region with elastic deformation shown to be the mechanism of compression for pressures greater than 70 MPa. This is in agreement with the plateau in the tensile strength observed for these powders at higher compression pressures (Fig. 8a) . Similar behaviour is shown by Formulation-3 (Fig. 9b ), but with a lesser degree of elastic deformation. Formulation-4 (Fig. 9c) , which maintained a linear relationship between tablet tensile strength and compression pressure for the pressures studied (Fig. 8a) , behaved close to linearly, even at the highest pressures. Previous studies have shown that while it is difficult to completely separate the contributions of plastic and elastic deformation mechanisms to the strength of a compact following compression, strength increases are mainly due to the formation of physical bonds between particles due to plastic deformation (Hiestand, 1997) . Much of the elastic deformation is temporary and disperses once the load is released (Picker, 2001) however it seems that in this case some tensile strength increase due to elastic deformation is permanent, indicated by the fact that the tensile strength of extruded powders in Fig. 8 continues to increase at higher pressures and does not completely plateau.
Dissolution studies
Dissolution profiles of tablets 1, 2, 3 and 4 are plotted in Fig. 10 . As expected, the formulations containing spray dried dispersions performed better than those containing milled extrudate Davis et al., 2017) . Drug concentrations at 2 h approximated 50 µg.mL −1 and 30 µg.mL −1 , respectively. After 6 h, average drug concentrations increased to 82.3 µg.mL −1 in tablet 1 (spray dried with (Table 4) before compression into spherical disks and dissolution (n = 3) in HCl (pH 1.2), with HPLC analysis at λ = 263 nm. Av200), 69.1 µg.mL −1 in tablet 2 (spray dried with ManG), 44.2 µg.mL −1 in tablet 3 (milled extrudate with Av200) and 44.5 µg.mL −1 in tablet 4 (milled extrudate with ManG). The highest drug release observed was from one of the spray dried and Av200 tablets, achieving a 91.0 µg.mL −1 concentration after 6 h, a drug release of 81.9%. The most immediate factors facilitating the higher performance of the spray dried material were the smaller particle size, narrower particle dimensions and larger particle surface area, relative to milled extrudate (Fig. 1) . Only the smaller sieved fraction (< 90 µm) of milled extrudate was brought though for dissolution studies, as this was closer in particle size to the spray dried formulation and therefore more comparable. For an absolute comparison an identical particle size would be best, although this would require a very small sieve fraction from the milled extrudate (or use of a jet mill) and a further enhancement of spray dried particle size by a factor of 5 to 10. This could be achieved using alternative spray drying parameters, such as a pressure nozzle (Beyerinck et al., 2010) .
Interestingly, the Av200 tablets performed better than the ManG tablets on average, however the results were not simplistic and at certain times the performance of ManG tablets exceeded Av200 tablets. For example, the Av200 formula out-performed the ManG formula during almost all of the milled extrudate tests, apart from the first half hour, where it was marginally higher and the final test point (6 h), where it was also marginally higher. Additionally, for the spray dried tests, the ManG formula out-performed the Av200 formula during the first 2 h, but this changed between 2 h and 3 h and the Av200 formulation then released more drug through to 6 h (Fig. 10) . Depending on the type of formulation required (e.g. immediate or sustained release) either of these results could be seen as a favourable direction for development. It is worth noting that although the ASD and 'filler' are present in each tablet at 66.6% and 30% (w/w) respectively, the impact of 'filler' excipient on each formulation is significant. For example, the highest recorded drug release (at 6 h) for spray dried with avicel was 91.0 µg.mL −1 and the lowest for spray dried with mannogem was 67.6 µg.mL
, a difference of 23.5 µg.mL −1 .
Clearly, formulation of either the spray dried or the extruded ASD into an optimised tablet is a very complex task and difficult to predict. Firstly, further studies are recommended for formulation optimisation, such as examining ASD level, filler type, filler level, lubricant level and other factors impacting dissolution rate; including the potential for gelling polymer networks (GPN) (Demuth et al., 2015) . Secondly, optimisation of tablet processing factors such as the effect of compression pressure on dissolution, the presence/absence of crystalline drug caused by compression, reduced particle surface area, disintegration time and wettability are also recommended. Finally, optimisation of processing parameters during ASD preparation, such as nozzle type, feed concentration, outlet temperature (for spray drying), or screw size, screw speed and sieve fraction (for extrusion) would further enhance control over critical parameters such as yield, processing time and particle size. Because an exhaustive trial of all possible permutations is impractical, a well-constructed design of experiment (DoE) approach appears the most straightforward and beneficial, given the potential for statistically relevant information based on fewer experimental trials. Optimisation of the formulation aspect of the ternary dispersions themselves using DoE has already been accomplished in this group and was recently reported in two separate publications Davis et al., 2017) .
Conclusions
The differences in downstream processing properties between amorphous solid dispersions prepared via hot melt extrusion or spray drying are significant. Preparation choice substantially impacted flow, compression and dissolution. The fundamental differences can be attributes to variances in particle size and morphology generated from the alternative preparation methods. Spray dried powders had smaller particles sizes, more complex morphology, were more cohesive and had poorer flow than milled extrudate. Good agreement was observed between various rheometric and density based parameters used to measure flow, such as Flow Function (FF), Relative flow function, Aeration ratio (AR), Flow rate index (FRI) and also the more rudimentary methods such as the Hausner ratio and Carr's index. Spray dried materials produced stronger compacts during tabletability studies and had lower solid fractions during compactability studies. Porosity studies revealed differences in the mechanism of densification in extrudate and blended extrudate formulations. It was possible to alter the flow and compression properties of the amorphous dispersions by blending with specific excipients. Dissolution studies on four prototype tablets containing 100 mg of amorphous itraconazole, revealed that drug release was faster and more complete from the spray dried samples and could be further influenced by selective excipient blending.
